394 related articles for article (PubMed ID: 34149687)
1. The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming.
Luque-Campos N; Bustamante-Barrientos FA; Pradenas C; García C; Araya MJ; Bohaud C; Contreras-López R; Elizondo-Vega R; Djouad F; Luz-Crawford P; Vega-Letter AM
Front Immunol; 2021; 12():624746. PubMed ID: 34149687
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-301a inhibition enhances the immunomodulatory functions of adipose-derived mesenchymal stem cells by induction of macrophage M2 polarization.
Hsu LW; Huang KT; Nakano T; Chiu KW; Chen KD; Goto S; Chen CL
Int J Immunopathol Pharmacol; 2020; 34():2058738420966092. PubMed ID: 33121303
[TBL] [Abstract][Full Text] [Related]
3. MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism.
Planat-Benard V; Varin A; Casteilla L
Front Immunol; 2021; 12():626755. PubMed ID: 33995350
[TBL] [Abstract][Full Text] [Related]
4. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stem and Stromal Cells Harness Macrophage-Derived Amphiregulin to Maintain Tissue Homeostasis.
Ko JH; Kim HJ; Jeong HJ; Lee HJ; Oh JY
Cell Rep; 2020 Mar; 30(11):3806-3820.e6. PubMed ID: 32187551
[TBL] [Abstract][Full Text] [Related]
6. Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.
Philipp D; Suhr L; Wahlers T; Choi YH; Paunel-Görgülü A
Stem Cell Res Ther; 2018 Oct; 9(1):286. PubMed ID: 30359316
[TBL] [Abstract][Full Text] [Related]
7. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
Front Immunol; 2018; 9():1078. PubMed ID: 29892282
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy.
Li K; Nie H; Jin R; Wu X
Front Immunol; 2024; 15():1397005. PubMed ID: 38779660
[TBL] [Abstract][Full Text] [Related]
9. Trained murine mesenchymal stem cells have anti-inflammatory effect on macrophages, but defective regulation on T-cell proliferation.
Lin T; Pajarinen J; Kohno Y; Huang JF; Maruyama M; Romero-Lopez M; Nathan K; Yao Z; Goodman SB
FASEB J; 2019 Mar; 33(3):4203-4211. PubMed ID: 30521384
[TBL] [Abstract][Full Text] [Related]
10. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
Front Immunol; 2020; 11():54. PubMed ID: 32117234
[TBL] [Abstract][Full Text] [Related]
11. Musculoskeletal Progenitor/Stromal Cell-Derived Mitochondria Modulate Cell Differentiation and Therapeutical Function.
Jorgensen C; Khoury M
Front Immunol; 2021; 12():606781. PubMed ID: 33763061
[TBL] [Abstract][Full Text] [Related]
12. The mechanisms of cellular crosstalk between mesenchymal stem cells and natural killer cells: Therapeutic implications.
Moloudizargari M; Govahi A; Fallah M; Rezvanfar MA; Asghari MH; Abdollahi M
J Cell Physiol; 2021 Apr; 236(4):2413-2429. PubMed ID: 32892356
[TBL] [Abstract][Full Text] [Related]
13. Current Concept and Update of the Macrophage Plasticity Concept: Intracellular Mechanisms of Reprogramming and M3 Macrophage "Switch" Phenotype.
Malyshev I; Malyshev Y
Biomed Res Int; 2015; 2015():341308. PubMed ID: 26366410
[TBL] [Abstract][Full Text] [Related]
14. Antiinflammatory activity of ANGPTL4 facilitates macrophage polarization to induce cardiac repair.
Cho DI; Kang HJ; Jeon JH; Eom GH; Cho HH; Kim MR; Cho M; Jeong HY; Cho HC; Hong MH; Kim YS; Ahn Y
JCI Insight; 2019 Aug; 4(16):. PubMed ID: 31434807
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells reprogram monocytes and macrophages with processing bodies.
Min H; Xu L; Parrott R; Overall CC; Lillich M; Rabjohns EM; Rampersad RR; Tarrant TK; Meadows N; Fernandez-Castaneda A; Gaultier A; Kurtzberg J; Filiano AJ
Stem Cells; 2021 Jan; 39(1):115-128. PubMed ID: 33166420
[TBL] [Abstract][Full Text] [Related]
16. A past and present overview of macrophage metabolism and functional outcomes.
Curi R; de Siqueira Mendes R; de Campos Crispin LA; Norata GD; Sampaio SC; Newsholme P
Clin Sci (Lond); 2017 Jun; 131(12):1329-1342. PubMed ID: 28592702
[TBL] [Abstract][Full Text] [Related]
17. Endometrial Mesenchymal Stem/Stromal Cells Modulate the Macrophage Response to Implanted Polyamide/Gelatin Composite Mesh in Immunocompromised and Immunocompetent Mice.
Darzi S; Deane JA; Nold CA; Edwards SE; Gough DJ; Mukherjee S; Gurung S; Tan KS; Vashi AV; Werkmeister JA; Gargett CE
Sci Rep; 2018 Apr; 8(1):6554. PubMed ID: 29700360
[TBL] [Abstract][Full Text] [Related]
18. Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors.
Saldaña L; Bensiamar F; Vallés G; Mancebo FJ; García-Rey E; Vilaboa N
Stem Cell Res Ther; 2019 Feb; 10(1):58. PubMed ID: 30760316
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cells Direct the Immunological Fate of Macrophages.
Luz-Crawford P; Jorgensen C; Djouad F
Results Probl Cell Differ; 2017; 62():61-72. PubMed ID: 28455706
[TBL] [Abstract][Full Text] [Related]
20. Macrophages in multiple myeloma: emerging concepts and therapeutic implications.
Asimakopoulos F; Kim J; Denu RA; Hope C; Jensen JL; Ollar SJ; Hebron E; Flanagan C; Callander N; Hematti P
Leuk Lymphoma; 2013 Oct; 54(10):2112-21. PubMed ID: 23432691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
